SINJARD-M 12.5/500 contains Empagliflozin 12.5 mg and Metformin Hydrochloride 500 mg. It is a combination oral antidiabetic medicine used to improve blood glucose control in patients with type 2 diabetes mellitus.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps control blood glucose levels along with diet and exercise
-
Empagliflozin helps reduce blood glucose by increasing glucose removal through urine
-
Metformin helps reduce glucose production by the liver and improves insulin sensitivity
-
May help reduce the risk of cardiovascular complications in eligible patients
Dose:
-
Adults: Usually 1 tablet once or twice daily with meals or as directed by a physician
-
Take with food to reduce stomach discomfort
-
Maintain adequate fluid intake as advised by a healthcare professional
-
Swallow the tablet whole; do not crush or chew unless advised
-
Dose depends on the patient’s condition, kidney function, and response to treatment
-
Follow the prescribed dose and duration as advised by a healthcare professional